Commentary: Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders

Clara Westwell-Roper; S Evelyn Stewart

doi:10.3389/fpsyt.2020.00264

Commentary: Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders

Front Psychiatry. 2020 Apr 22:11:264. doi: 10.3389/fpsyt.2020.00264. eCollection 2020.

Authors

Clara Westwell-Roper^{1

2}, S Evelyn Stewart^{1

2

3}

Affiliations

¹ Department of Psychiatry, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
² British Columbia Children's Hospital Research Institute, Vancouver, BC, Canada.
³ BC Mental Health and Substance Use Services Research Institute, Vancouver, BC, Canada.

No abstract available

Keywords: COX-2 inhibitor; child and adolescent psychiatric disorders; immunopsychiatry; inflammation; innate immunity; non-steroidal anti-inflammatory drug; obsessive compulsive disorder; prostanoid.

Publication types

Comment